转移素结合的纳米结构脂质载体用于向色素到黑色素瘤细胞
1Pharmaceutical Sciences Department, MCPHS University, 179 Longwood Ave, Boston, MA 02115, USA.
International journal of molecular sciences
|August 29, 2024
概括
这项研究开发了转激素结合的纳米结构脂质载体 (NLC) 用于抗疟疾药物阿尔泰米松 (ATM). 这种新的配方显著增强了ATM的功能.
科学领域:
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 由于药物发现成本上升,药物重新定位至关重要.
- 对抗疟疾药物阿尔泰米松 (ATM) 的抗癌性质进行了研究.
- 纳米结构脂质载体 (NLCs) 提供了改善药物输送的潜力.
研究的目的:
- 在纳米结构脂质载体 (NLC) 中配制阿米松 (ATM).
- 创建转激素结合的NLCs (NLC-Tf) 来增强ATM传递和抗癌活性.
- 评估ATM载NLC和NLC-Tf在黑色素瘤细胞系中的疗效.
主要方法:
- 使用高压均质化和超声波制备NLC配方.
- 特性包括粒子大小,泽塔潜力和多分散度指数 (PDI).
- 通过IR光谱证实了转移素 (Tf) 与NLC的结合;使用MTS试验评估了抗癌活性.
主要成果:
- 配方表现出纳米尺寸范围 (140-167纳米) 与不同的泽塔电位.
- 红外光谱学证实了Tf与NLC的成功结合.
- 与单独使用ATM相比,ATM装载的NLC-Tf显示出对黑色素瘤细胞的细胞毒性显著增加.
结论:
- 作为运送ATM到黑色素瘤细胞的载体,NLCs显示出前途.
- 转林结合显著增强了阿尔特米松的抗癌疗效.
- 这种方法提供了一个可行的策略,用于重新利用抗疟疾药物用于癌症治疗.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


